Mª Carmen García Guerrero
María del Carmen García Guerrero (Granollers, 1986) obtained her degree in Biochemistry from the Autonomous University of Barcelona (UAB) in 2010. She followed up with a post-graduate course in biotechnology applied to the pharmaceutical and related industries, awarded by the University Institute of Science and Technology (IUCT) in 2011, and an MSc in Biochemistry, Molecular Biology and Biomedicine, awarded by the UAB in 2012.
In 2013 she obtained a university instructor training (FPU) grant to pursue a PhD in the Protein and Proteomic Engineering Laboratory attached to the UAB Institute of Biotechnology and Biomedicine. During her doctoral studies, she worked mainly on the biochemical characterization of key human proteases and their inhibitors. She was awarded her PhD in Biochemistry, Molecular Biology and Biomedicine in 2017. She is now employed as a laboratory technician in IrsiCaixa’s Retrovirology and Clinical Studies group led by Dr. Javier Martínez-Picado.
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.
Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.